Evidence map›Paper›PMID 36615943›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Josefina Ballarre, Daniel Buldain, Irem Unalan, Juan I Pastore, Nora Mestorino, Aldo R Boccaccini

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Antibacterial Nanostructured Coatings.Nanomaterials (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Josefina BallarreMaterial's Science and Technology Research Institute (INTEMA), UNMdP-CONICET, Av. Colón 10850, Mar del Plata B7600, Argentina.ORCID 0000-0002-9804-863X
Daniel BuldainPharmacologic and Toxicological Studies Laboratory (LEFyT), Veterinary Science Faculty, UNLP, La Plata B1900, Argentina.
Irem UnalanDepartment of Materials Science and Engineering, Institute of Biomaterials, University of Erlangen-Nuremberg, Cauerstrasse 6, 91058 Erlangen, Germany.ORCID 0000-0002-4729-0012
Juan I PastoreNational Council of Scientific and Technical Research (CONICET), Argentina.
Nora MestorinoPharmacologic and Toxicological Studies Laboratory (LEFyT), Veterinary Science Faculty, UNLP, La Plata B1900, Argentina.ORCID 0000-0002-5580-428X
Aldo R BoccacciniDepartment of Materials Science and Engineering, Institute of Biomaterials, University of Erlangen-Nuremberg, Cauerstrasse 6, 91058 Erlangen, Germany.ORCID 0000-0002-7377-2955
Friedrich-Alexander-Universität Erlangen-Nürnberg · DECentro Científico Tecnológico - San Juan · ARConsejo Nacional de Investigaciones Científicas y Técnicas · ARNational University of Mar del Plata · ARUniversidad Nacional de La Plata · AR

Funding

Alexander von Humboldt Foundation Experienced Researcher Fellowship
6 · The paper itself

Abstract

Bioactive glasses have been proposed for bone tissue engineering due to their excellent biocompatibility and osteo-inductive behaviour. The generation of mesoporous bioactive glass (nano) particles adds a high surface area for the dissolution and release of bioactive ions, and the possibility to load them with different drugs for antibacterial purposes. Essential oils (EO) are an interesting resource for alternative medical therapy, providing antimicrobial compounds that come from organic/natural resources like aromatic plants. Also, a biological polymer, such as chitosan, could be used to control the release of active agents from mesoporous bioactive glass (MBG) loaded particles. This work presents MBG particles with nominal composition (in mol) 60% SiO

Indexed as

antibacterial propertiesessential oilMelaleuca armillarismesoporous bioactive glass

Identifiers

PMID36615943
PMCPMC9824681
OpenAlexW4313511089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.